Looking to the future of oncology
April 9, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CAR T, CAR-T, Cancer, feature, oncology, pharma
The oncology field moves so quickly that it can be hard to keep track of the latest innovations. Ben Hargreaves …
Almost 40% of UK prostate cancer cases are diagnosed late, according to report
April 9, 2018Medical Communications, Research and Development, Sales and Marketing Cancer, UK, pharma, prostate cancer
A report conducted by charity Orchid has revealed a “worrying trend” in the treatment of prostate cancer, indicating that as …
Facebook takes action against drug peddlers on Instagram
April 9, 2018Medical Communications, Sales and Marketing Facebook, biotech, drugs, fentanyl, instagram, opioid, opioid epidemic, pharma, pharmaceutical
Facebook can’t catch a break at the moment, after being widely criticised for its practices over the security of users’ …
Tecentriq third time lucky after NICE nod in lung cancer
April 9, 2018Sales and Marketing NICE, Roche, biotech, drugs, lung cancer, pharma, pharmaceutical, tecentriq
After having been knocked by twice by NICE, Roche has finally received a recommendation for Tecentriq’s second-line use in non-small …
Keytruda combo fails at Phase 3 in metastatic melanoma
April 9, 2018Research and Development, Sales and Marketing Incyte, MSD, keytruda, pharma, trial failure
Shares in biopharma firm Incyte were sent reeling by as much as 20% when the company announced that the results …
Novartis CEO makes mark with $8.7bn AveXis acquisition
April 9, 2018Sales and Marketing AveXis, Novartis, biotech, drugs, gene therapy, pharma, pharmaceutical
Vas Narasimhan’s first few moves as CEO of Novartis indicate that he is not afraid to take bold risks in …
Samsung Bioepis and Biogen secure licensing deal with Abbvie for Humira biosimilar
April 6, 2018Medical Communications, Sales and Marketing AbbVie, Biogen, Humira, Imraldi, Samsung Bioepis, biosimilar, pharma
Partners Biogen and Samsung Bioepis have secured the future of their Humira (adalimumab) biosimilar after penning a deal with Abbvie …
Top Ten most popular articles on Pharmafile.com this week
April 6, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, Boehringer Ingelheim, Kite, Nordic Nanovector, Pfizer, Roche, Sanofi, biotech, cystic fibrosis, drugs, pharma, pharmaceutical
Some of the biggest news this week concerns companies that are looking to move on parts of their business, but …
Roche suffers Ocrevus knockback by NICE
April 6, 2018Medical Communications, Sales and Marketing Ocrevus, Roche, biotech, drugs, multiple sclerosis, pharma, pharmaceutical
Roche’s multiple sclerosis drug, Ocrevus (ocrelizumab), has been a big new growth driver for the company, especially in the US, …
J&J pays out $37m in damages over claims its talc contains asbestos
April 6, 2018Medical Communications, Sales and Marketing Cancer, J&J, JJ, Johnson & Johnson, mesothelioma, ovarian cancer, pharma, talc
Bad news for Johnson & Johnson as it emerges that the US pharma giant has been ordered to pay out …
Takeda move for Shire looks increasingly likely
April 6, 2018Medical Communications, Sales and Marketing Japan, Shire, Takeda, UK, biotech, drugs, pharma, pharmaceutical
Takeda’s surprise announcement, just last week, that it was weighing up a move for Shire had some analysts sceptical about …
Nordic Nanovector CEO steps down as company delays R&D timelines
April 5, 2018Medical Communications, Research and Development, Sales and Marketing Luigi Costa, Nordic Nanovector, pharma
Norwegian biopharmaceutical firm Nordic Nanovector has revealed that its Chief Executive Officer Luigi Costa is set to step down from …
Transforming cystic fibrosis treatment
April 5, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Vertex, biotech, cystic fibrosis, drugs, pharma, pharmaceutical
Fred van Goor, Principle Research Fellow at Vertex Pharmaceuticals, discusses his history of work in cystic fibrosis and how the …
Roche snaps up Inception neuroscience program
April 5, 2018Sales and Marketing Pipeline Therapeutics, Roche, biotech, drugs, pharma, pharmaceutical
Back in 2014, Roche entered into strategic collaboration with Inception Sciences to look into the regenerative medicines space for multiple …
Boehringer teams up with OSE in €1.1 billion cancer drug partnership
April 5, 2018Sales and Marketing Boehringer, Cancer, OSE Immunotherapeutics, partnership, pharma
Boehringer Ingelheim and biotech firm OSE Immunotherapeutics have announced that they have entered an exclusive collaboration and license agreement to …
Obesity admissions double in four years
April 5, 2018Medical Communications NHS, UK, biotech, drugs, pharma, pharmaceutical
New figures show that hospital admissions related to obesity have doubled over the last four years in the UK, placing …
Lilly and Sigilon team up in $473m+ deal to ‘cure’ diabetes
April 5, 2018Sales and Marketing Eli Lilly, Sigilon Therapeutics, biotech, drugs, pharma, pharmaceutical
Eli Lilly and Sigilon Therapeutics have announced a partnership that looks to break new ground in the management of type …
NICE rejects Dupixent for atopic dermatitis on cost grounds, Sanofi responds
April 4, 2018Research and Development, Sales and Marketing Dupixent, NICE, Sanofi, atopic dermatitis, eczema, pharma
UK drug watchdog NCIE has issued draft guidance rejecting the routine use of Sanofi’s Dupixent (dupilumab) for the treatment of …
Proton beam therapy finally arrives in UK
April 4, 2018Medical Communications, Research and Development NHS, Proton beam therapy, biotech, drugs, pharma, pharmaceutical
28 years after the US first pioneered proton beam therapy at Loma Linda University Medical Center, the UK now has …
Twin-drug combo effectively shrinks lung cancers by blocking their “escape route”
April 4, 2018Research and Development Cancer, epidermal growth factor, lung cancer, pharma, tumour necrosis factor
A study conducted by researchers at UT Southwestern’s Simmons Cancer Center has revealed that a combination of two specific drug …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
